v2.4.0.8
Share-Based Compensation (Tables)
12 Months Ended
Dec. 28, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Number and Weighted Average Exercise Price of Options Issued and Outstanding under All Stock Option Plans
The number and weighted average exercise price of options issued and outstanding under all stock option plans are as follows (in thousands, except for exercise price):
 
Year ended
December 28, 2013
 
Year ended
December 29, 2012
 
Year ended
December 31, 2011
 
Shares
 
Average
Exercise
Price
 
Shares
 
Average
Exercise
Price
 
Shares
 
Average
Exercise
Price
Options outstanding, beginning of period
8,368

 
$
22.78

 
8,277

 
$
22.68

 
6,941

 
$
21.32

Granted
1,653

 
$
21.17

 
754

 
$
22.17

 
2,277

 
$
23.85

Canceled
(795
)
 
$
24.53

 
(447
)
 
$
27.30

 
(312
)
 
$
27.62

Expired

 
$

 

 
$

 

 
$

Exercised
(315
)
 
$
10.49

 
(216
)
 
$
7.62

 
(629
)
 
$
9.44

Options outstanding, end of period
8,911

 
$
22.76

 
8,368

 
$
22.78

 
8,277

 
$
22.68

Options exercisable, end of period
5,188

 
$
22.69

 
4,632

 
$
21.29

 
3,636

 
$
19.45

Options available for grant, end of period
5,795

 
 
 
4,934

 
 
 
3,493

 
 
Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant
The range of assumptions used and the resulting weighted-average fair value of options granted at the date of grant were as follows:
 
Year ended
December 28, 2013
 
Year ended
December 29, 2012
 
Year ended
December 31, 2011
Risk-free interest rate
0.7% to 1.8%
 
0.7% to 1.3%
 
0.9% to 2.5%
Expected term
5.1 years to 5.5 years
 
5.5 years to 5.5 years
 
5.3 years to 5.5 years
Estimated volatility
31.2% to 39.6%
 
36.6% to 42.6%
 
36.7% to 43.2%
Expected dividends
0%
 
0%
 
0%
Weighted-average fair value of options granted
$7.53 per share
 
$7.98 per share
 
$9.44 per share
Total Share-Based Compensation Expense Included in Consolidated Statements of Comprehensive Income
The following table presents the total share-based compensation expense that is included in each functional line item of the consolidated statements of comprehensive income (in thousands):
 
Year ended
December 28,
2013
 
Year ended
December 29,
2012
 
Year ended
December 31,
2011
Cost of goods sold
$
354

 
$
480

 
$
383

Selling, general and administrative
9,407

 
10,775

 
10,268

Research and development
1,913

 
2,842

 
3,025

Total
$
11,674

 
$
14,097

 
$
13,676

Number and Weighted Average Exercise Price of Outstanding and Exercisable Options
The schedule below reflects the number and weighted average exercise price of outstanding and exercisable options segregated by exercise price ranges (in thousands, except remaining contractual life):
 
December 28, 2013
 
December 29, 2012
 
Options Outstanding
 
Options
Exercisable
 
Options Outstanding
 
Options
Exercisable
Range of Exercise Prices
Number of
Options
 
Average
Remaining
Contractual
Life
 
Number of
Options
 
Number of
Options
 
Average
Remaining
Contractual
Life
 
Number of
Options
$2.75 to $4.00
279

 
1.01
 
279

 
425

 
1.49
 
425

$4.67 to $12.00
696

 
2.46
 
696

 
745

 
3.44
 
745

$12.87 to $16.00
549

 
3.39
 
549

 
580

 
4.39
 
580

$17.84 to $23.98
3,635

 
8.06
 
986

 
2,592

 
8.25
 
662

$24.00 to $28.99
1,708

 
6.20
 
1,077

 
1,811

 
6.98
 
885

$29.07 to $31.99
1,734

 
5.37
 
1,311

 
1,902

 
6.30
 
1,090

$32.21 to $38.30
117

 
5.28
 
98

 
117

 
6.28
 
75

$38.60 to $41.51
193

 
4.40
 
192

 
196

 
5.41
 
170

Total
8,911

 
6.12
 
5,188

 
8,368

 
6.40
 
4,632